Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

pancreatic cancer

  • Open Access
    Clinical Impact of Nutrition and Inflammation Assessment Tools in Pancreatic Cancer Treatment
    TORU AOYAMA, YUKIO MAEZAWA, ITARU HASHIMOTO, YASUSHI RINO and TAKASHI OSHIMA
    Anticancer Research September 2023, 43 (9) 3849-3860; DOI: https://doi.org/10.21873/anticanres.16572
  • You have access
    FOLFIRINOX in Pancreatic Cancer: Risk Factors for Febrile Neutropenia and Severe Neutropenia — Nationwide Study Analysis
    AKIKO TODAKA, MITSUHITO SASAKI, HIDEKI UENO, TAKUMA GOTO, GOU MUROHISA, NOBUMASA MIZUNO, MASATO OZAKA, SATOSHI KOBAYASHI, KAZUHIRO UESUGI, NORITOSHI KOBAYASHI, HIDEYUKI HAYASHI, KENTARO SUDO, NAOHIRO OKANO, YOSUKE HORITA, KEIKO KAMEI, SHOKO NANAMI and NARIKAZU BOKU
    Anticancer Research September 2023, 43 (9) 4115-4123; DOI: https://doi.org/10.21873/anticanres.16601
  • You have access
    High Preoperative Serum D-dimer Predicts Unfavorable Survival Outcomes for Pancreatic Cancer Patients
    TOMOHISA OTSU, MASAMICHI HAYASHI, HIDEKI TAKAMI, YOSHIKUNI INOKAWA, NOBUTAKE TANAKA, KEISUKE KURIMOTO, KOKI NAKANISHI, SHINICHI UMEDA, DAI SHIMIZU, NORIFUMI HATTORI, MITSURO KANDA, CHIE TANAKA, GORO NAKAYAMA and YASUHIRO KODERA
    Anticancer Research July 2023, 43 (7) 3173-3181; DOI: https://doi.org/10.21873/anticanres.16491
  • Open Access
    KRAS Mutation Analysis Using Cell-free DNA of Pancreatic Cancer
    YORIHIKO TAKASE, YOSHIKI NAITO, AKIHIKO KAWAHARA, YOSHINOBU OKABE, EIJI SADASHIMA, HIDEYUKI ABE and JUN AKIBA
    Anticancer Research June 2023, 43 (6) 2683-2690; DOI: https://doi.org/10.21873/anticanres.16434
  • Open Access
    The Novel Use of IL-28 as an Effective Radiosensitizer in Pancreatic Cancer
    XUHUI CHEN, HAYDEN Y. LEE, TRIEN T. TANG, CHENGLU QIN, SAMUEL A. PRISSEL, CHRISTIAN J. NELSON, LUKE A. SMITH, HUAPING XIAO, QIAN BAI, MICHAEL B. NICHOLL, MARK R. WAKEFIELD and YUJIANG FANG
    Anticancer Research May 2023, 43 (5) 1885-1890; DOI: https://doi.org/10.21873/anticanres.16347
  • You have access
    Incidence and Risk of Venous Thromboembolism in Patients With Resectable Pancreatic Cancer Receiving Neoadjuvant Chemotherapy
    MARIKO KAMIYA, SHINNOSUKE KAWAHARA, YUTO KAMIOKA, MASAAKI MURAKAWA, TORU AOYAMA, SATOSHI KOBAYASHI, MAKOTO UENO, NAOTO YAMAMOTO, TAKASHI OSHIMA, NORIO YUKAWA, YASUSHI RINO, MUNETAKA MASUDA and SOICHIRO MORINAGA
    Anticancer Research April 2023, 43 (4) 1741-1747; DOI: https://doi.org/10.21873/anticanres.16327
  • You have access
    Conversion Surgery for Unresectable Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel
    YASUSHI IDE, TAIGA OTSUKA, MOTOTSUGU SHIMOKAWA, FUTA KOGA, YUJIRO UEDA, JUNICHI NAKAZAWA, AZUSA KOMORI, SATOSHI OTSU, SHIHO ARIMA, MASARU FUKAHORI, AKITAKA MAKIYAMA, YUDAI SHINOHARA, SHOHEI UENO, HIROKI TAGUCHI, TAKUYA HONDA, TARO SHIBUKI, KENTA NIO, NORIO URESHINO, TOSHIHIKO MIZUTA, KENJI MITSUGI and TSUYOSHI SHIRAKAWA
    Anticancer Research April 2023, 43 (4) 1817-1826; DOI: https://doi.org/10.21873/anticanres.16335
  • Open Access
    Cyclodextrin Conjugated α-Bisabolol Suppresses FAK Phosphorylation and Induces Apoptosis in Pancreatic Cancer
    MIKIKO TAKEBAYASHI KANO, TOSHIO KOKURYO, TAISUKE BABA, KIMITOSHI YAMAZAKI, JUNPEI YAMAGUCHI, MASAKI SUNAGAWA, ATSUSHI OGURA, NOBUYUKI WATANABE, SHUNSUKE ONOE, KAZUSHI MIYATA, TAKASHI MIZUNO, KAY UEHARA, TSUYOSHI IGAMI, YUKIHIRO YOKOYAMA, TOMOKI EBATA and MASATO NAGINO
    Anticancer Research March 2023, 43 (3) 1009-1016; DOI: https://doi.org/10.21873/anticanres.16245
  • Open Access
    Treatment of Human Pancreatic Cancers Following Local and Systemic Administration of Oncolytic Adenovirus Serotype 35
    RYOSUKE ONO, KOSUKE TAKAYAMA, RIKA ONISHI, SORA TOKUOKA, FUMINORI SAKURAI and HIROYUKI MIZUGUCHI
    Anticancer Research February 2023, 43 (2) 537-546; DOI: https://doi.org/10.21873/anticanres.16190
  • You have access
    Antitumor Effects of Deep Ultraviolet Irradiation for Pancreatic Cancer
    KIMITOSHI YAMAZAKI, TOSHIO KOKURYO, JUNPEI YAMAGUCHI, MASAKI SUNAGAWA, ATSUSHI OGURA, NOBUYUKI WATANABE, SHUNSUKE ONOE, KAZUSHI MIYATA, TAKASHI MIZUNO, KAY UEHARA, TSUYOSHI IGAMI, YUKIHIRO YOKOYAMA, TOMOKI EBATA and MASATO NAGINO
    Anticancer Research February 2023, 43 (2) 621-630; DOI: https://doi.org/10.21873/anticanres.16198

Pages

  • Previous
  • Next
  • 1
  • …
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 25
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire